Contact this trialFirst, we need to learn more about you.
Platinum-based Chemotherapy
Chemo-Immunotherapy for Recurrent Ovarian Cancer
Recruiting1 awardPhase 1 & 2
Pittsburgh, Pennsylvania
This trial will test a new combination of drugs to treat ovarian cancer. The drugs will be given through IV and intraperitoneal (IP) infusion. The trial will evaluate the effectiveness and safety of the new combination.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.